Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

GSK plc ADR buy melinda

Start price
€31.40
22.06.23 / 10%
Target price
€35.00
22.06.24
Performance (%)
19.11%
End price
€37.40
23.06.24
Summary
This prediction ended on 23.06.24 with a price of €37.40. The prediction had a final performance of 19.11%. Dividends of €1.37 are taken into consideration when calculating the performance. melinda has 10% into this prediction This prediction was marked as speculative and is excluded from melinda's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
GSK plc ADR 0.556% 0.556% 12.422%
iShares Core DAX® -0.543% 1.491% 13.638%
iShares Nasdaq 100 -2.696% -1.235% 31.879%
iShares Nikkei 225® -2.863% 2.491% 12.078%
iShares S&P 500 -1.105% 0.013% 26.888%

According to melinda what are the pros and cons of GSK plc ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread GlaxoSmithKline plc ADR diskutieren
Prediction Buy
Perf. (%) 19.11%
Target price 35.000
Change
Ends at

Buy mit Kursziel 35,0

In the thread Trading GlaxoSmithKline plc ADR
Prediction Buy
Perf. (%) 19.11%
Target price 35.000
Change
Ends at 22.06.24

Die von melinda gewählte maximale Laufzeit wurde überschritten

Stopped prediction by melinda for GSK plc ADR

buy
GSK plc ADR

Start price
Target price
Perf. (%)
€41.25
15.09.21
€43.75
15.09.22
-16.61%
15.08.22

Could be worthwhile Investment >10% per year